Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,890.00
-100.00 (-1.67%)
At close: May 29, 2025, 3:30 PM KST

Vivozon Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
86,33387,60171,31851,56457,56043,592
Upgrade
Other Revenue
-0-0---0-
Upgrade
Revenue
86,33387,60171,31851,56457,56043,592
Upgrade
Revenue Growth (YoY)
11.38%22.83%38.31%-10.42%32.04%-3.03%
Upgrade
Cost of Revenue
41,23642,19439,99730,12837,92136,461
Upgrade
Gross Profit
45,09745,40731,32121,43719,6397,130
Upgrade
Selling, General & Admin
40,45537,11125,08223,03128,62710,427
Upgrade
Research & Development
3,7123,5722,5411,9273,9352,870
Upgrade
Operating Expenses
50,11247,20826,61131,24339,25315,169
Upgrade
Operating Income
-5,015-1,8004,709-9,806-19,615-8,039
Upgrade
Interest Expense
-2,301-2,254-2,904-5,271-7,297-10,792
Upgrade
Interest & Investment Income
150.61170.39345.14840.79909.591,274
Upgrade
Earnings From Equity Investments
-1,404-1,470-2,821--691.35-
Upgrade
Currency Exchange Gain (Loss)
0.81-58.49-6.07125.03999.14-774.58
Upgrade
Other Non Operating Income (Expenses)
-3,811-4,160-43.59-940-402.961,782
Upgrade
EBT Excluding Unusual Items
-12,380-9,572-720.44-15,051-26,097-16,549
Upgrade
Gain (Loss) on Sale of Investments
-4.077.32-812.22-4,84269.4-3,621
Upgrade
Gain (Loss) on Sale of Assets
76.0476.21-596.57-102.92-229.9337.98
Upgrade
Asset Writedown
-1,054-1,054-29.21-5,252-49,590-23,990
Upgrade
Other Unusual Items
----92.74--
Upgrade
Pretax Income
-13,362-10,543-2,158-25,342-75,848-43,822
Upgrade
Income Tax Expense
123.68123.6855.271,509-4,833263.27
Upgrade
Earnings From Continuing Operations
-13,486-10,666-2,214-26,851-71,015-44,085
Upgrade
Earnings From Discontinued Operations
718.16684.46-1,143-13,827--
Upgrade
Net Income to Company
-12,767-9,982-3,357-40,677-71,015-44,085
Upgrade
Minority Interest in Earnings
---771.551,558330.6
Upgrade
Net Income
-12,767-9,982-3,357-39,906-69,457-43,754
Upgrade
Net Income to Common
-12,767-9,982-3,357-39,906-69,457-43,754
Upgrade
Shares Outstanding (Basic)
484848443326
Upgrade
Shares Outstanding (Diluted)
484848443326
Upgrade
Shares Change (YoY)
1.50%0.06%9.69%33.41%24.52%24.63%
Upgrade
EPS (Basic)
-264.11-209.06-70.35-917.27-2129.90-1670.65
Upgrade
EPS (Diluted)
-264.11-209.06-70.35-917.27-2130.00-1670.65
Upgrade
Free Cash Flow
-1,056-2,719-1,532-9,814-27,6083,755
Upgrade
Free Cash Flow Per Share
-21.86-56.95-32.10-225.59-846.59143.39
Upgrade
Gross Margin
52.24%51.83%43.92%41.57%34.12%16.36%
Upgrade
Operating Margin
-5.81%-2.05%6.60%-19.02%-34.08%-18.44%
Upgrade
Profit Margin
-14.79%-11.39%-4.71%-77.39%-120.67%-100.37%
Upgrade
Free Cash Flow Margin
-1.22%-3.10%-2.15%-19.03%-47.96%8.62%
Upgrade
EBITDA
-1,2341,7647,937-6,162-14,062-5,860
Upgrade
EBITDA Margin
-1.43%2.01%11.13%-11.95%-24.43%-13.44%
Upgrade
D&A For EBITDA
3,7803,5643,2283,6435,5522,179
Upgrade
EBIT
-5,015-1,8004,709-9,806-19,615-8,039
Upgrade
EBIT Margin
-5.81%-2.05%6.60%-19.02%-34.08%-18.44%
Upgrade
Advertising Expenses
-343.73617.321,6884,4191,037
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.